Redsense Medical launches digital training platform
Halmstad, Sweden, June 26, 2026 – Redsense Medical AB (publ) (“Redsense'' or “the Company”) announces the launch of a new digital training platform for healthcare professionals, healthcare providers and distributors.
The platform brings Redsense training materials, product information, quick guides, tutorials, contact details and other educational resources into one central location. The purpose is to make training and retraining more accessible and to support consistent use of Redsense products across markets.
Easier access to training helps healthcare professionals stay confident in the daily use of Redsense products, supporting safer dialysis care for the patients who rely on them.
In the United States, Redsense is coordinating access together with the education and training departments of several of its largest healthcare provider customers. Outside the United States, healthcare professionals and distributors will be able to request access through Redsense’s website or through local distribution partners.
“The training platform makes it easier for healthcare professionals and distributors to access the information and support they need in one place. By supporting onboarding, retraining and consistent use of Redsense products, we help healthcare professionals deliver safer dialysis care for their patients,” says Sebastien Bollue, CEO of Redsense Medical AB.
Contact information
For more information, please contact:
Sebastien Bollue, CEO
Telephone: +46 72-171 1264
E-mail: sebastien.bollue (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter eakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS)